Patent ID: 7894994

Claim:
A computer-implemented method comprising: accepting, in a suitably programmed computing device, input identifying an epithelial target cell population; accepting, in a suitably programmed computing device, input identifying at least one specified alteration in metabolic activity in at least a part of the epithelial target cell population; accepting, in a suitably programmed computing device, input identifying at least one specified alteration in telomerase activity in at least a part of the epithelial target cell population; selecting at least one metabolic-alteration agent in response to the input alteration in metabolic activity in the at least the part of the epithelial target cell population; selecting at least one telomerase-activity-alteration agent in response to the input alteration in telomerase activity in the at least the part of the epithelial target cell population; selecting at least one combination of at least one said metabolic-alteration agent and at least one said telomerase-activity-alteration agent, wherein the selected at least one combination is associated with at least one treatment option and is associated with topical administration; and indicating, in a suitably programmed computing device, the selected at least one combination to at least one system user.